Search

Search Constraints

You searched for: Author/Creator Schernthaner, Guntram

Search Results

2. Canagliflozin provides greater attainment of both HbA1c and body weight reduction versus sitagliptin in patients with type 2 diabetes. Issue 8 (16th November 2016)

3. CARMELINA: An important piece of the DPP-4 inhibitor CVOT puzzle. (July 2019)

7. Dipeptidyl peptidase-4 inhibition with linagliptin and effects on hyperglycaemia and albuminuria in patients with type 2 diabetes and renal dysfunction: Rationale and design of the MARLINA–T2D™ trial. (November 2015)

8. Exploring the Possible Impact of Unbalanced Open-Label Drop-In of Glucose-Lowering Medications on EXSCEL Outcomes. Issue 17 (28th April 2020)